The head of a stakeholder group told the Food and Drug Administration (FDA) Wednesday that funding has not kept pace with the agency's ever-expanding portfolio.
Diane Dorman, president of the Alliance for a Stronger FDA, told the agency's Science Board that the current $2.5 billion budget is "dramatically less" than the FDA requires.
"This amount might have met the FDA's funding needs in late 2007 ... but not now," Dorman said.
Read more: http://thehill.com/blogs/healthwatch/medical-devices-and-prescription-drug-policy-/285309-advocate-says-fda-mission-at-risk-from-lack-of-funds#ixzz2MAf3aifI
Follow us: @thehill on Twitter | TheHill on Facebook
Diane Dorman, president of the Alliance for a Stronger FDA, told the agency's Science Board that the current $2.5 billion budget is "dramatically less" than the FDA requires.
"This amount might have met the FDA's funding needs in late 2007 ... but not now," Dorman said.
Read more: http://thehill.com/blogs/healthwatch/medical-devices-and-prescription-drug-policy-/285309-advocate-says-fda-mission-at-risk-from-lack-of-funds#ixzz2MAf3aifI
Follow us: @thehill on Twitter | TheHill on Facebook
No comments:
Post a Comment